Cannara Biotech Reports Q2 2024 Financial Results
Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase. Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4.0...
Stay updated with breaking news from Effective April. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase. Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4.0...
Effective April 26, 2024, Evgen Pharma plc will change its London Stock Exchange AIM Market stock ticker symbol to TCF from EVG....
Effective April 24, 2024, Sahacogen Public Company Limited will change its name to Ratch Pathana Energy Public Company Limited....
NEW YORK and VIENNA, Austria, April 24, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of...
NEW YORK and VIENNA, Austria, April 24, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class...